Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Syneron Medical Ltd (NASDAQ:ELOS)

9.53
Delayed Data
As of Aug 28
 +0.18 / +1.93%
Today’s Change
8.32
Today|||52-Week Range
12.90
+2.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues60.3M74.1M63.4M73.5M
 
 
 
 
 
Cost of Goods Sold25.5M31.9M28.5M32.7M
 
 
 
 
 
Depreciation And Amortization2.5M1.8M2.2M2.2M
 
 
 
 
 
 
Operating ExpensesGross Income32.3M40.3M32.7M38.5M
 
 
 
 
 
General Expenses32.9M37.5M34.0M39.4M
 
 
 
 
 
Research And Development5.8M6.5M5.7M6.2M
 
 
 
 
 
Total Operating Expenses60.8M71.3M64.7M74.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-592.0K2.8M-1.3M-821.0K
 
 
 
 
 
Extraordinary Charge---4.6M--0.00
 
 
Other Expenses-1.3M1.3M-299.0K1.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.9M-483.0K-1.6M219.0K
 
 
 
 
 
Income Taxes-442.0K-886.0K-128.0K-509.0K
 
 
 
 
 
Net Income-2.3M-1.4M-1.5M-290.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS36.8M36.8M36.7M36.5M
 
 
 
 
 
Shares To Calculate EPS Diluted36.8M36.8M36.7M36.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.04-$0.04-$0.01
 
 
 
 
 
EPS Diluted-$0.06-$0.04-$0.04-$0.01